Back
Pure Cycle 10K Form
Sell
34
PCYO
Pure Cycle
Last Price:
13.07
Seasonality Move:
14.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-07-10 | 10Q | PCYO/Pure Cycle Quarterly |
| 2024-04-10 | 10Q | PCYO/Pure Cycle Quarterly |
| 2024-01-16 | 10Q | PCYO/Pure Cycle Quarterly |
| 2023-11-15 | 10K | PCYO/Pure Cycle Annual |
| 2023-07-14 | 10Q | PCYO/Pure Cycle Quarterly |
| 2023-04-14 | 10Q | PCYO/Pure Cycle Quarterly |
Receive PCYO News And Ratings
See the #1 stock for the next 7 days that we like better than PCYO
PCYO Financial Statistics
Sales & Book Value
| Annual Sales: | $14.59M |
|---|---|
| Cash Flow: | $2.38M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.12 |
| Price / Book: | 2.29 |
Profitability
| EPS (TTM): | 0.25490 |
|---|---|
| Net Income (TTM): | $6.06M |
| Gross Margin: | $8.04M |
| Return on Equity: | 5.06% |
| Return on Assets: | 4.5% |
Pure Cycle Earnings Forecast
Key Pure Cycle Financial Ratios
- The Gross Profit Margin over the past 27 years for PCYO is 55.12%.
- The Selling, General & Administrative Expenses for PCYO have been equal to 37.50% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 4.38% of Operating Income.
- The Net Earning history of PCYO is 32.22% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 14 years.
Pure Cycle Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Water Utilities |
| Sector: | Utilities |
| Current Symbol: | PCYO |
| CUSIP: | 746228 |
| Website: | purecyclewater.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 3.17 |
| Quick Ratio: | 2.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 61.68 |
|---|---|
| Forward P/E Ratio: | 0 |
PCYO Technical Analysis vs Fundamental Analysis
Sell
34
Pure Cycle (PCYO)
is a Sell
Is Pure Cycle a Buy or a Sell?
-
Pure Cycle stock is rated a Sell
The current Pure Cycle [PCYO] share price is $11.71. The Score for PCYO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.